Company intelligence / Profile preview

BioAnalyte

Portland, Maine, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

BioAnalyte is a life science informatics company that specializes in developing advanced software for the analysis of mass spectrometry data. Its flagship product, Magellan, is designed to automate the characterization of proteins, peptides, and glycans, significantly reducing the time required for manual data interpretation. The company's technology is utilized by biopharmaceutical companies and research laboratories to streamline workflows in proteomics and drug development. BioAnalyte's solutions are particularly effective for analyzing complex mixtures and identifying post-translational modifications. Based in Portland, Maine, the company has been a niche provider of high-performance analytical tools since its founding in 2001.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on BioAnalyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioAnalyte.

Explore the full profile